APO-Bortezomib bortezomib 3.5mg powder for injection vial

Country: অস্ট্রেলিয়া

ভাষা: ইংরেজি

সূত্র: Department of Health (Therapeutic Goods Administration)

সক্রিয় উপাদান:

bortezomib, Quantity: 3.5 mg

থেকে পাওয়া:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Bortezomib

ফার্মাসিউটিকাল ফর্ম:

Injection, powder for

রচনা:

Excipient Ingredients: mannitol

প্রশাসন রুট:

Subcutaneous, Intravenous

প্যাকেজ ইউনিট:

1

প্রেসক্রিপশন টাইপ:

(S4) Prescription Only Medicine

থেরাপিউটিক ইঙ্গিত:

Bortezomib, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy.,Bortezomib, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma.,Bortezomib is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy and who have progressive disease.

পণ্য সারাংশ:

Visual Identification: White to off-white powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

অনুমোদন অবস্থা:

Licence status A

অনুমোদন তারিখ:

2015-07-22